Active Ingredient(s):Maralixibat Chloride FDA Approved: * September 29, 2021 Pharm Company: *MIRUM Category:Genetic Disorders
Maralixibat chloride, sold under the brand name Livmarli, is a medication used to treat cholestatic pruritus in people with Alagille syndrome. Maralixibat chloride is an ileal bile acid transporter (IBAT) inhibitor.
Maralixibat was approved for medical use in the United States in September 2021.
4 External links
Maralixibat was granted orphan dr...
* May have multiple approval dates, manufacturers, or labelers.